Qilu Pharmaceutical Competitors and Similar CompaniesClear all

Qilu Pharmaceutical's competitors and similar companies include STA Pharmaceutical, Hetero, WuXi AppTec and Catalent.
Qilu Pharmaceutical
Qilu Pharmaceutical
Qilu Pharmaceutical (齐鲁制药) is a company that develops, manufactures, and markets generic drugs and active pharmaceutical ingredients (APIs).
STA Pharmaceutical
STA Pharmaceutical
STA Pharmaceutical (also known as WuXi STA, 合全药业, 上海合全药业股份有限公司) is a contract development and manufacturing organization (CDMO) serving the life sciences industry.
Hetero
Hetero
Hetero is a generic pharmaceutical company engaged in the development, manufacturing, and marketing of chemical and biologic drugs.
WuXi AppTec
WuXi AppTec
WuXi AppTec (无锡药明康德新药开发股份有限公司, formerly known as WuXi PharmaTech) is a company that provides integrated research, development, and manufacturing solutions for drug discovery and production.
Catalent
Catalent
Catalent is a company that develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, vaccines, and consumer health products.
Founding Date
Founding Date
1958
Founding Date
2000
Founding Date
1993
Founding Date
2000
Founding Date
2007
Type
Type
Private
Type
Subsidiary
Type
Private
Type
Public
Type
Subsidiary
Tags
Locations
Locations
Jinan Shi, CN HQ
Boston, US
Locations
Shanghai, CN HQ
Locations
Hyderabad, IN HQ
Norwest, AU
Sao Paulo, BR
Beijing, CN
Nanjing Shi, CN
Nanjing Shi, CN
Bogotá, CO
see more
Locations
Shanghai, CN HQ
Beijing, CN
Changzhou, CN
Chengdu, CN
Nanjing, CN
Nantong, CN
Shanghai, CN
see more
Locations
Bridgewater, US HQ
Buenos Aires, AR
Bruxelles, BE
Charleroi, BE
Charleroi, BE
Charleroi, BE
Indaiatuba, BR
see more
Employees
Employees
39,0008% increase
Employees
4261% increase
Employees
7,0042% increase
Employees
39,414
Employees
12,6955% increase

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
N/A
Revenue (est.)
N/A
Revenue (est.)
¥43.1b (FY, 2025)
Revenue (est.)
$4.4b (FY, 2024)
Cost of goods
Cost of goods
N/A
Cost of goods
N/A
Cost of goods
N/A
Cost of goods
¥23.8b (FY, 2025)
Cost of goods
$3.4b (FY, 2024)
Gross profit
Gross profit
N/A
Gross profit
N/A
Gross profit
N/A
Gross profit
¥21.3b (FY, 2025)
Gross profit
$953m (FY, 2024)
Net income
Net income
N/A
Net income
N/A
Net income
N/A
Net income
¥19.3b (FY, 2025)
Net income
($1b) (FY, 2024)

Operating

Countries
Countries
N/A
Countries
N/A
Countries
126 (Jan, 2021)
Countries
N/A
Countries
80 (FY, 2023)
Products
Products
N/A
Products
N/A
Products
200 (Jan, 2021)
Products
N/A
Products
8 k (FY, 2023)
Scientists and Researchers
Scientists and Researchers
N/A
Scientists and Researchers
N/A
Scientists and Researchers
1 k (Jan, 2021)
Scientists and Researchers
38 k (H1, 2023)
Scientists and Researchers
N/A

Funding

Total funding raised
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
$ 902.6m
Total funding raised
$ 650m
For sources of this data, please see the company profile

View Company Profiles

STA Pharmaceutical
HQ
Shanghai, CN

STA Pharmaceutical (also known as WuXi STA, 合全药业, 上海合全药业股份有限公司) is a contract development and manufacturing organization (CDMO) serving the life sciences industry.

View company
Hetero
HQ
Hyderabad, IN
Employees
7,004↑ 2% increase

Hetero is a generic pharmaceutical company engaged in the development, manufacturing, and marketing of chemical and biologic drugs.

View company
WuXi AppTec
HQ
Shanghai, CN
Employees
39,414

WuXi AppTec (无锡药明康德新药开发股份有限公司, formerly known as WuXi PharmaTech) is a company that provides integrated research, development, and manufacturing solutions for drug discovery and production.

View company
Catalent
HQ
Bridgewater, US

Catalent is a company that develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, vaccines, and consumer health products.

View company